Home Newsfeeds Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $50 to $52.

byBenzinga Newsdesk

August 1, 2022

1 minute read

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $50 to $52.

Enveric Biosciences Announces New U.S. Patent For C4-Carboxylic Acid-Substituted Tryptamine Derivatives

By Happy Mohamed

September 5, 8:03 AM

New patent provides additional composition of matter and methods of use claims for Enveric's tryptamine-derived prodrugs including EB-373, a new chemical entity psilocin prodrug Enveric Biosciences (NASDAQ:ENVB)

ENVB

TikTok Sets Limits For Gen Z’s Screen Time — Finally, A Digital Nanny For The Digital Natives!

By Ananya Gairola

March 2, 3:42 AM

Chinese video-sharing app TikTok announced a new approach to mitigate its addictive nature and address concerns about the…

What’s Going On With Walmart Stock Friday?

By Nabaparna Bhattacharya

May 17, 1:18 PM

Walmart inaugurates a new fulfillment center in Greencastle, enhancing fast shipping and creating over 1,000 jobs for the region.

WMT

Advance Auto Parts Revises FY23 Outlook: Revenue $11.25B – $11.35B ($11.2B – $11.3B Prior) Vs. $11.21B Estimate, EPS $4.50 – $5.10 ($6.00 – $6.50 Prior) Vs. $5.92 Estimate, Comparable store Sales (0.5%) – 0.5% Up From (1%) – Flat Prior

By Benzinga Newsdesk

August 23, 6:34 AM

Prior FY 2023 Outlook Updated FY 2023 Outlook As of May 31, 2023 As of August 23,

AAP

Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Related Posts

Enveric Biosciences Announces New U.S. Patent For C4-Carboxylic Acid-Substituted Tryptamine Derivatives

TikTok Sets Limits For Gen Z’s Screen Time — Finally, A Digital Nanny For The Digital Natives!

What’s Going On With Walmart Stock Friday?

Advance Auto Parts Revises FY23 Outlook: Revenue $11.25B – $11.35B ($11.2B – $11.3B Prior) Vs. $11.21B Estimate, EPS $4.50 – $5.10 ($6.00 – $6.50 Prior) Vs. $5.92 Estimate, Comparable store Sales (0.5%) – 0.5% Up From (1%) – Flat Prior